Does hypertension predispose to coronary disease? conflicting epidemiological and experimental evidence

American Journal of Hypertension

Volumn 1, Issue 3, 1988, Pages 319-324

  Doyle, Austin E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coronary atherosclerosis; Hypertension; Hypertensive heart failure; Myocardial infarction

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; REVIEW; RISK FACTOR;

CORONARY DISEASE; DISEASE SUSCEPTIBILITY; HUMAN; HYPERTENSION;

EID: 0023923246     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/1.3.319     Document Type: Article

References (19)

1. Gordon T, Kannell WB: The Framingham study, Section 30 (DHEW publ. no. NIH74-599). Government Printing office, Washington 1974
2. Anderson TW: Re-examination of some of the Framing- ham blood pressure data. Lancet 1978;2:1139-1141
3. Report by the Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980; 1:1261-67
4. Amery A, Brixko P, Clement D, et al: Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet 1985, 1:1349- 54
5. Helgeland A, Hjermann I, Leren P, et al: High density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J 1978;2:403
6. Helgeland A, Hjermann I, Leren P: Possible metabolic side effects of beta-adrenergic blocking drugs. Br Med J 1978;1:828
7. Norwegian Multicentre Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807
8. Goldring W, Chasis H: Hypertension and hypotensive disease. NY Commonwealth Fund 1945
9. Bell ET, Clawson BJ: Primary (essential) hypertension. A study of four hundred and twenty cases. Arch Pathol 1928;5:939-1001
10. Bulpitt CJ, Beevers DG, Butler A, et al: The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP) J Hypertension 1986;4:93-99
11. Hodge JV, Smirk FH: The effect of drug treatment of hypertension on the distribution of death from various causes. Am Heart J 1967;73:441-452
12. Dollery CT, Hartlet K, Bulpitt PF, et al: Fifteen year sur- vival of patients beginning treatment with Methyldopa between 1962 and 1966. Hypertension 1984;6(5 part 2):2-82—2-86
13. Isles CG, Walker LM, Beevers DG, et al: Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertension 1986;4:141-156
14. Davis D, Klainer MJ: Studies in hypertensive heart disease. II. The role of hypertension, per se, in the develop- ment of coronary sclerosis. Am Heart J 1940, 19:193- 197
15. Davis D, Klainer MJ: Studies in hypertensive heart disease. I. The incidence of coronary atherosclerosis in cases of essential hypertension. Am Heart J 1940;19:185-192
16. Harrison CV, Wood P: Hypertensive and ischaemic heart disease: a comparative clinical and pathological study. Br Heart J 1949; 11:205-209
17. Stewart I McD G: Relation of reduction in pressure to first myocardial infarction in patients receiving treat- ment for severe hypertension. Lancet 1979;1:861-865
18. Stewart I McD G: β-Adrenoceptor blockade and the inci- dence of myocardial infarction during treatment of severe hypertension. Br J Clin Pharmacol 1982;13:91-93
19. Wilhelmsen L, Berglund G, Elmfeldt D, et al: Beta- blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens 1987;561- 572